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OBJECTIVES We evaluated the long-term results of perforation of the pulmonary valve in patients with
pulmonary atresia with an intact ventricular septum (PA-IVS).
BACKGROUND Interventional perforation of the pulmonary valve is considered the elective first stage
treatment for PA-IVS, particularly in patients with a tripartite right ventricle (RV) and
normal coronary circulation. However, the long-term results of this procedure are lacking.
METHODS Between January 1991 and December 2001, 39 newborns with a favorable form of PA-IVS
underwent attempted perforation of the pulmonary valve. We evaluated the early and
long-term outcomes.
RESULTS Median tricuspid and pulmonary z values were 1.2 and 2.4, respectively. Perforation was
successful in 33 patients. Among them, 17 needed neonatal surgery, 13 did not need any
surgery, and 3 had elective surgery after the first month of life. There were two procedure-
related deaths, seven nonfatal procedural complications, and four postsurgical deaths.
Compared with patients needing neonatal surgery, those having no or elective surgery had a
higher incidence of a tripartite RV and a higher median tricuspid z value (92% vs. 53%, p 
0.04 and 1.7 vs. 0.5, p  0.03). At a median follow-up of 5.5 years (range 0.5 to 11.5),
survival was 85% and freedom from surgery was 35%. Five patients, four of whom had
neonatal surgery, underwent a partial cavo-pulmonary connection.
CONCLUSIONS Our results show that this technique, although burdened by non-negligible mortality and
morbidity, is effective in selected patients with a normal-sized RV. Preselection of patients
allows interventional or surgical biventricular correction in the majority of cases. (J Am Coll
Cardiol 2003;41:1399–403) © 2003 by the American College of Cardiology Foundation
Pulmonary atresia with an intact ventricular septum (PA-
IVS) is a complex congenital heart disease that has a wide
morphologic diversity. The degree of right ventricular (RV)
hypoplasia, the presence of a patent infundibulum, and the
occurrence of right ventriculo-coronary connections
strongly influence the therapeutic approach (1–3). In the
forms with moderate RV hypoplasia, a patent infundibu-
lum, and an atretic or imperforate pulmonary valve, RV
decompression has been advocated as the initial palliative
procedure (4). This goal can be achieved surgically or by
interventional perforation of the pulmonary valve (5). Dur-
ing the last 10 years, interventional catheterization has been
chosen as the elective primary treatment for favorable forms
of PA-IVS (6–11). This procedure is feasible either by a
guide wire, radiofrequency, or laser, with a relatively low
periprocedural risk (6,8,10). However, most investigators
have shown that, at early follow-up, the large majority of
patients still needs palliative cardiac surgery (10,12). In
addition, small series of patients primarily treated by perfo-
ration of the pulmonary valve have been examined so far
(5,6,8,12), and data on long-term follow-up are lacking.
In our institution, this technique was introduced in 1991.
The purpose of this study was to review our experience,
focusing attention on early and long-term results. We also
tried to identify criteria that could predict the need for
neonatal surgery, despite successful perforation of the pul-
monary valve.
METHODS
Patients. Between January 1991 and December 2001, 39
newborns with favorable forms of PA-IVS underwent
attempted perforation of the pulmonary valve. Inclusion
criteria did not change during the study period. They
included neonates and infants with an unoperated PA-IVS,
bipartite or tripartite RV, tricuspid z value not less than
3.5, pulmonary z value not less than 5, absent or mild
Ebstein anomaly, and normal coronary anatomy. The ex-
clusion criteria included a monopartite RV, coronary fistulae
with RV-dependent coronary circulation, and moderate to
severe Ebstein anomaly. The z value was defined as follows:
(measured diameter  mean normal diameter)/(standard
deviation of mean normal diameter). The population in-
cluded 18 males and 21 females. The median age and
weight at perforation were three days (range 1 to 90) and 3
kg (range 2 to 4), respectively. One patient had quadrisomy
of chromosome X. Two patients had a mild Ebstein
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anomaly of the tricuspid valve. The RV was bipartite in 12
and tripartite in 27 patients. The median tricuspid diameter
was 11 mm (range 7 to 18), and the median tricuspid z value
was 1.2 (range 3.5 to 1.5). The median diameter of the
atretic pulmonary annulus was 7 mm (range 5 to 9), and the
median pulmonary z value was 2.4 (range 4.5 to 1.5).
All but three patients, who had a patent ductus arteriosus
and underwent a late diagnosis, were under prostaglandin
(PG) infusion.
Transcatheter procedure. The femoral vein was cannu-
lated using a 4F or 5F sheath. All patients underwent RV
angiography in the lateral and/or four-chamber view to
exclude RV-dependent coronary circulation and to visualize
the pulmonary infundibulum. Guide-wire perforation was
obtained by pushing the rigid extremity of a variety of guide
wires against the pulmonary valvular plane through a 4F or
5F Judkins right catheter. Radiofrequency valvotomy was
performed using the Medtronic Cardiorhythm generator
(Rueil Mailmaison, France) connected to a Cerablate PA
120 unipolar catheter (Osypka, Rheinfelden-Herten, Ger-
many) through a 5F Judkins right catheter. After successful
valvotomy, a 0.014-in. or 0.018-in. coronary guide wire was
passed into the descending aorta through the pulmonary
artery and patent ductus arteriosus. Sequential dilations of
the pulmonary valve were then performed, until obtaining a
full opening of the pulmonary annulus. The RV to aortic
pressure ratio was measured before and after successful
dilation of the pulmonary valve. Procedural failure was
defined as the inability to perforate the atretic valve.
Follow-up. Patients were gradually weaned from PG in-
fusion. Patients who, after successful perforation, continued
to have inadequate anterograde pulmonary flow and hypox-
emia, underwent a Blalock-Taussig (B/T) shunt procedure.
The B/T shunt was associated with the right ventricular
outflow tract (RVOT) patch when the outflow tract was
hypoplastic or stenotic.
Persistent infundibular stenosis with or without pulmo-
nary valve stenosis was an indication to use a late, elective
RVOT patch. Patients with persistent systemic desaturation
at rest and a right to left shunt through an atrial septal defect
(ASD) or patent foramen ovale underwent a partial cavo-
pulmonary connection (PCPC).
Patients with mild desaturation on effort (95%) and
unchanged right atrial pressure during test occlusion of
ASD underwent ASD interventional closure. Patients with
normal saturation at rest and during test occlusion of the
B/T shunt underwent interventional embolization.
Hospital records were reviewed for any surgical or inter-
ventional procedure and for the most recent clinical and
echocardiographic evaluation. We took into account the
arterial oxygen saturation at rest and on effort, the right to
left shunt through an ASD or foramen ovale, and the
residual pulmonary stenosis.
On the basis of follow-up data, the patients were classi-
fied into two outcome groups: the “no neonatal surgery”
group (n  16) comprised patients who, after successful
perforation of the pulmonary valve, did not need any
surgical procedure, or needed elective surgery after the
neonatal period and had no or mild cyanosis on effort at late
follow-up. The “neonatal surgery” group (n  17) com-
prised patients who, despite successful perforation of the
pulmonary valve, needed neonatal surgery.
Statistical analysis. For analysis of data, we used the
statistical package SAS version 6.12. The Kaplan-Meier test
was employed for analysis of survival and freedom from
surgery. The paired Student t test was used to compare
hemodynamic values before and after interventional cathe-
terization. The Wilcoxon and Fisher exact tests were em-
ployed to compare variables between the “no neonatal
surgery” and “neonatal surgery” groups. For statistical anal-
ysis, patients with a patent ductus arteriosus and late
diagnosis were excluded. Age, weight, and anatomic values
were expressed as the median value and range. A p value
0.05 was considered statistically significant.
RESULTS
Figure 1 summarizes the results of interventional and
surgical procedures. Perforation, obtained by a guide wire in
20 and by radiofrequency in 19 patients, was successful in 33
(85%). Right ventricular pressure fell from 112 21 to 49.6
 9.7 mm Hg (p 0.001). There were six (15%) procedural
complications (2 deaths due to infundibular perforation, 1
pericardial effusion, 3 cases of atrial flutter) and three (8%)
postprocedural complications (3 cases of necrotizing entero-
colitis). Infusion of PG was continued for a median period
of 12 days (range 4 to 40). At a median follow-up of 15 days
(range 1 to 30), 21 patients, all under PG therapy, needed
cardiac surgery (12 B/T shunts, 8 B/T shunt plus RVOT
patch, 1 RVOT patch). There were four (19%) postsurgical
deaths. Two more patients had an elective RVOT patch
after the neonatal period. Four patients had redilation of the
pulmonary valve at 13, 11, 20, and 1.5 months; three had
interventional shunt embolization at 12 and 29 months and
6 years, and three had interventional closure of their ASD at
5, 6, and 4 years. In the “no neonatal surgery” group, no
patient underwent interventional catheterization after the
first perforation of the pulmonary valve. Four patients who
had previous neonatal surgery and one unoperated patient
underwent PCPC. None had the Fontan operation.
Abbreviations and Acronyms
ASD  atrial septal defect
BT  Blalock-Taussig
NYHA  New York Heart Association
PA-IVS  pulmonary atresia with intact ventricular
septum
PCPC  partial cavo-pulmonary connection
PG  prostaglandin
RV  right ventricle/ventricular
RVOT  right ventricular outflow tract
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Thus, at a median follow-up of 5.5 years (range 0.5 to
11.5), 13 patients did not need any surgery, and three had
elective surgery after the neonatal period. The remaining
patients needed neonatal surgery, four due to failed perfo-
ration and 17 despite successful perforation of the pulmo-
nary valve. Table 1 illustrates the anatomic “predictors of
outcome” in the “no neonatal surgery” and “neonatal sur-
gery” groups. Patients who needed neonatal surgery had a
tricuspid z value significantly smaller than that of patients
who did not need neonatal surgery; 47% of them had a
bipartite RV. In this group, the pulmonary annulus was
smaller than that in the “no neonatal surgery” group, but not
significantly so. No patient in the “no neonatal surgery”
group had a tricuspid z value less than 2 and a pulmonary
z value less than 3; all but one had a tripartite RV.
Nevertheless, two patients with tricuspid and pulmonary z
values 0 and a tripartite RV needed neonatal surgery.
The neonatal mortality rate was 15%. No late deaths
occurred. Figure 2 illustrates the freedom from surgery.
Neonatal surgery was needed in 52% of patients with a
successful pulmonary perforation. Overall late freedom from
surgery was 35%. Nine patients needed multiple operations.
At the last clinical and echocardiographic examination, all
patients except one, who had a chromosomal anomaly, were
in New York Heart Association (NYHA) functional class I.
Cyanosis at rest was present in seven patients: two are
waiting for PCPC; two have PCPC with a mild right to left
shunt at the atrial level; and three have a mild right to left
shunt through a patent foramen ovale and are waiting for its
interventional closure. One patient had mild cyanosis on
effort. No patient has residual pulmonary stenosis. Mild to
moderate pulmonary incompetence was present in five
patients and tricuspid incompetence in one. All patients
with PCPC have nonobstructed flow in the anastomosis.
DISCUSSION
Perforation of the pulmonary valve, introduced for the first
time in 1991 by Qureshi et al. (13) has been validated by
various investigators (6,8–10). The successful perforation
rate ranges between 75% and 100% (6,8,10,12); however, a
perioperative mortality rate up to 17% has been reported
(12). When selecting patients for perforation, choosing only
those with favorable forms has worked to diminish
procedure-related death and improve outcome (6). Never-
theless, perforation of the infundibulum, sepsis, and multi-
organ failure are not occasional complications (5,7,10,12).
In our series, perforation was obtained in 85% of cases. The
procedural mortality rate was 5% and procedural morbidity
was 12%, due to either pericardial effusion or arrhythmias.
We confirmed a non-negligible incidence of necrotizing
enterocolitis in neonates who remained duct-dependent
after successful pulmonary valve dilation (14).
After a successful procedure, the impaired compliance of
the RV often prevents the surgeon from avoiding neonatal
surgery. The reported need of a B/T shunt and/or RVOT
patch ranges from 0% to 75% (6,10). This large variability is
likely linked to anatomic differences among the treated
patients or to different attitudes regarding the maximal
accepted duration of PG infusion. In our series, neonatal
surgery was needed in more than 50% of infants with
successful valve perforation. Various authors have high-
lighted the increased risk of surgery in duct-dependent
patients (12). This could be explained by prolonged hypox-
emia, chronic vasodilation, poor trophism, immunodepres-
sion, and tissue edema, all generally found in these patients
(14). In this setting, we reported a 24% postsurgical mor-
tality rate, due to either sepsis or shunt thrombosis, whereas
no deaths occurred in patients undergoing immediate sur-
Figure 1. Flow chart summarizing the procedures and outcomes (death or no death) of patients.
Table 1. Anatomic Characteristics of Patients Who Did Not Need or Who Needed Neonatal
Surgery
No Neonatal Surgery
Group (n  13)
Neonatal Surgery
Group (n  17)
p
Value
Tripartite right ventricle (%) 92 53 0.04
Median tricuspid z value 0.5 1.7 0.03
Median pulmonary z value 0.5 1.5 0.14
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gery after failed perforation. Nevertheless, other investiga-
tors have reported a high mortality in patients undergoing
urgent surgery after failed perforation (12).
The morphologic characteristics of the RV are considered
to be the main determinant of outcome; thus, the main
concern is the preselection of patients. Even if it has been
shown that even very hypoplastic RVs can grow (12,15–17),
most authors agree that biventricular repair is unlikely to be
attained when the tricuspid z value is less than 4 (18). In
addition, it has been demonstrated that patients needing
interventional catheterization only must have a tricuspid z
value greater than 0.5 and a pulmonary z value greater
than 4 (7,19).
Our data show that biventricular correction was attained
in 87% of patients. All but one patient who did not need
neonatal surgery had a tripartite RV. None of them had a
tricuspid z value less than 2 and a pulmonary z value less
than 2.8. Nevertheless, although patients needing neona-
tal surgery had a tricuspid z value significantly smaller than
that of patients who did not need any surgery, three patients
with tricuspid and pulmonary z values 0 needed neonatal
surgery. Other investigators have highlighted some mor-
phologic overlapping between groups of patients with dif-
ferent outcomes, suggesting that factors promoting RV
growth have not been completely identified (12,15).
Thus, if an accurate preselection of patients is mandatory
for obtaining biventricular repair, it is probably insufficient
to identify patients who will not need any surgery.
Although an elective surgical approach for patients with
PA-IVS is known to have an elevated mortality (20),
recently, some authors have reconsidered the surgical treat-
ment as an alternative to pulmonary valve perforation (5,8).
The results are discordant due to different populations
examined and a different surgical approach. As no random-
ized studies have compared interventional versus surgical
treatment for unselected or selected patients with PA-IVS,
it is difficult to establish the best first-stage treatment.
Mid-term survival in our series was similar to that
previously reported (5,10,12). Publications on mid-term
and late outcomes are scanty. Our data show that, after the
neonatal period, mortality was zero and freedom from
surgery decreased only slightly, confirming that neonatal
strategy and outcome are strictly linked.
The results at mid-term follow-up are excellent for
patients treated either by surgery or catheterization in terms
of NYHA functional class, incidence of systemic desatura-
tion, and pulmonary and tricuspid valve function. Repeated
interventional catheterization was observed in the large
majority (59%) of patients who needed neonatal surgery, but
not in any patient who did not need surgery, confirming that
different populations of patients are treated and that, again,
a strict preselection of patients is mandatory before choosing
either the surgical or interventional approach.
Conclusions. Our results show that perforation of the
pulmonary valve, although carrying non-negligible mortality
and morbidity, is effective in selected patients with a
normal-sized RV. Preselection of patients allows biventricu-
lar correction in the majority of them. Limiting the inter-
ventional approach to forms of PA-IVS with a tripartite RV
and a tricuspid z value no less than 2 will probably allow
us to identify more precisely patients in whom biventricular
circulation will be restored by pulmonary valve perforation
only.
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